These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15634875)

  • 1. Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells.
    Valenzuela JO; Hammerbeck CD; Mescher MF
    J Immunol; 2005 Jan; 174(2):600-4. PubMed ID: 15634875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine.
    Curtsinger JM; Johnson CM; Mescher MF
    J Immunol; 2003 Nov; 171(10):5165-71. PubMed ID: 14607916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells.
    Valenzuela J; Schmidt C; Mescher M
    J Immunol; 2002 Dec; 169(12):6842-9. PubMed ID: 12471116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Il-12 enhances CD8 T cell homeostatic expansion.
    Kieper WC; Prlic M; Schmidt CS; Mescher MF; Jameson SC
    J Immunol; 2001 May; 166(9):5515-21. PubMed ID: 11313390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pim kinase pathway contributes to survival signaling in primed CD8+ T cells upon CD27 costimulation.
    Peperzak V; Veraar EA; Keller AM; Xiao Y; Borst J
    J Immunol; 2010 Dec; 185(11):6670-8. PubMed ID: 21048108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming in the presence of IL-10 results in direct enhancement of CD8+ T cell primary responses and inhibition of secondary responses.
    Kang SS; Allen PM
    J Immunol; 2005 May; 174(9):5382-9. PubMed ID: 15843536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo impact of CpG1826 oligodeoxynucleotide on CD8 T cell primary responses and survival.
    Beloeil L; Tomkowiak M; Angelov G; Walzer T; Dubois P; Marvel J
    J Immunol; 2003 Sep; 171(6):2995-3002. PubMed ID: 12960324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo.
    Schmidt CS; Mescher MF
    J Immunol; 1999 Sep; 163(5):2561-7. PubMed ID: 10452994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12-programmed long-term CD8+ T cell responses require STAT4.
    Li Q; Eppolito C; Odunsi K; Shrikant PA
    J Immunol; 2006 Dec; 177(11):7618-25. PubMed ID: 17114431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28.
    Kim EY; Teh HS
    J Immunol; 2004 Oct; 173(7):4500-9. PubMed ID: 15383581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.
    Sabbagh L; Pulle G; Liu Y; Tsitsikov EN; Watts TH
    J Immunol; 2008 Jun; 180(12):8093-101. PubMed ID: 18523273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells.
    Chang J; Cho JH; Lee SW; Choi SY; Ha SJ; Sung YC
    J Immunol; 2004 Mar; 172(5):2818-26. PubMed ID: 14978082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells.
    Berard M; Brandt K; Bulfone-Paus S; Tough DF
    J Immunol; 2003 May; 170(10):5018-26. PubMed ID: 12734346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15R.
    Ye Z; Shi M; Xu S; Xiang J
    Mol Immunol; 2010 Aug; 47(14):2411-21. PubMed ID: 20569988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of naive CD8 T cells requires persistent antigen and is not programmed by an initial signal from the tolerogenic APC.
    Redmond WL; Hernandez J; Sherman LA
    J Immunol; 2003 Dec; 171(12):6349-54. PubMed ID: 14662832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential survival of transferred CD8 T cells and host reconstitution depending on TCR avidity for host-expressed alloantigen.
    Auphan-Anezin N; Schmitt-Verhulst AM
    J Immunol; 2001 Jun; 166(12):7200-7. PubMed ID: 11390468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective delivery of augmented IL-2 receptor signals to responding CD8+ T cells increases the size of the acute antiviral response and of the resulting memory T cell pool.
    Cheng LE; Greenberg PD
    J Immunol; 2002 Nov; 169(9):4990-7. PubMed ID: 12391213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 T cells require Bcl-3 for maximal gamma interferon production upon secondary exposure to antigen.
    Chilton PM; Mitchell TC
    Infect Immun; 2006 Jul; 74(7):4180-9. PubMed ID: 16790793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.